Epidemiologic characteristics of invasive group B streptococcal infections caused by rare serotypes among adults in the United States, 2007–2023
Using CDC's Active Bacterial Core surveillance data, we observed increasing incidence of rare group B Streptococcus serotypes VI and VIII, from 0.007 and 0 cases per 100,000 in 2007 to 0.14 and 0.13 in 2023, respectively. These serotypes disproportionally impacted American Indian/Alaska Native, Asian, and Native Hawaiian/Pacific Islander populations.
Authors
- Allison Taffet (ORCID: https://orcid.org/0009-0001-0946-0842)
- Stephanie J. Schrag (ORCID: https://orcid.org/0000-0002-8113-2544)
- Namrata Prasad (ORCID: https://orcid.org/0000-0002-2268-279X)
- Benjamin J. Metcalf (ORCID: https://orcid.org/0000-0002-9628-2051)
- Adam J. Ratner (ORCID: https://orcid.org/0000-0003-1761-794X)
- Sydney Haldeman
Institutions
- Centers for Disease Control and Prevention (US)
- New York University (US)
Publication Details
- Journal
- PLOS Global Public Health
- Published
- 2026-04-21
- DOI
- https://doi.org/10.1371/journal.pgph.0006205
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of Allergy and Infectious Diseases